Beneficial Effect of Oral Bisphosphonate Treatment on Bone Loss Induced by Chronic Administration of Furosemide without Alteration of Its Administration and Urinary Calcium Loss

Bisphosphonate is widely used to treat patients with primary and secondary osteoporosis. The chronic administration of furosemide is considered a risk factor for osteoporosis mainly due to the increased urinary excretion of calcium, leading to a long-term negative balance of calcium. We describe two...

Full description

Saved in:
Bibliographic Details
Main Authors: Kubota, Takuo, Namba, Noriyuki, Kurotobi, Shunji, Kogaki, Shigetoyo, Hirai, Haruhiko, Kitaoka, Taichi, Nakajima, Shigeo, Ozono, Keiichi
Format: Artigo
Language:Inglês
Published: The Japanese Society for Pediatric Endocrinology 2006
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4004841/
https://ncbi.nlm.nih.gov/pubmed/24790329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1297/cpe.15.101
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items